You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》东曜药业(01875.HK)暗盘收报6.13元 低上市价6.4%
阿思达克 11-07 18:41

根据辉立交易平台显示,明天挂牌的东曜药业(01875.HK)暗盘高开10.7%报7.25元欠承接,掉头低见5.92元,收报6.13元,较上市价6.55元,低6.4%或0.42元,成交193万股,涉资1,200万元。

东曜是内地一间临床阶段仍未有盈利的生物制药公司,致力於开发和商业化创新型肿瘤药物及疗法。是次上市共发售9,000万股,并已引入3名基石投资者,包括控股股东晟德大药厂、主要股东Vivo Capital及在台上市的年兴纺织旗下年兴维京群岛,合共认购2,392.84万股(禁售期六个月);10%公开发售获近12倍超购,认购一手中签率15%;股份以招股范围(6.55-7.55元)下限定价,料集资净额约5.11亿元,主要用作为TAB008的进行中和计划进行临床试验、注册备案准备及潜在商业推出(包括销售及营销)提供资金、用作为研发中的其他在研产品提供资金,以及用於非项目特定资本开支等。上市独家保荐人工银国际融资。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account